5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.47%
Revenue growth under 50% of VALMT.HE's 28.34%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-13.70%
Negative gross profit growth while VALMT.HE is at 27.54%. Joel Greenblatt would examine cost competitiveness or demand decline.
-8.65%
Negative EBIT growth while VALMT.HE is at 51.58%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.65%
Negative operating income growth while VALMT.HE is at 51.58%. Joel Greenblatt would press for urgent turnaround measures.
-12.90%
Negative net income growth while VALMT.HE stands at 33.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.64%
Negative EPS growth while VALMT.HE is at 34.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.64%
Negative diluted EPS growth while VALMT.HE is at 34.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
0.86%
Diluted share change of 0.86% while VALMT.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
102.71%
OCF growth 1.25-1.5x VALMT.HE's 70.18%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
54.81%
FCF growth 50-75% of VALMT.HE's 97.14%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-7.66%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 29.34%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
28.63%
5Y revenue/share CAGR at 50-75% of VALMT.HE's 50.10%. Martin Whitman would worry about a lagging mid-term growth trajectory.
14.18%
3Y revenue/share CAGR at 50-75% of VALMT.HE's 22.19%. Martin Whitman would question if the firm lags behind competitor innovations.
759.93%
10Y OCF/share CAGR above 1.5x VALMT.HE's 219.39%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
130.01%
5Y OCF/share CAGR above 1.5x VALMT.HE's 8.23%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
297.47%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
130.76%
Below 50% of VALMT.HE's 1561.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
191.88%
Below 50% of VALMT.HE's 655.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
38.43%
3Y net income/share CAGR similar to VALMT.HE's 35.27%. Walter Schloss would attribute it to shared growth factors or demand patterns.
116.64%
10Y equity/share CAGR at 50-75% of VALMT.HE's 217.78%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
68.95%
5Y equity/share CAGR 1.25-1.5x VALMT.HE's 47.79%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
29.57%
3Y equity/share CAGR at 50-75% of VALMT.HE's 40.60%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.29%
Firm’s AR is declining while VALMT.HE shows 12.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.86%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.47%
Asset growth 1.25-1.5x VALMT.HE's 4.64%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
3.51%
Under 50% of VALMT.HE's 9.45%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
36.92%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.